DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Zepbound (tirzepatide) for chronic weight management and OSA with obesity. State telehealth scope, insurance coverage, and verified providers serving Alabama residents.
For weight-loss indication, Alabama Medicaid coverage is excludes. T2D coverage requires documented A1C ≥7.5% on metformin for 3 months. Zepbound requires the weight-loss PA pathway; review Alabama Medicaid criteria carefully.
Most Alabama commercial plans cover Zepbound with prior authorization. PA criteria typically require BMI ≥ 30 (or ≥ 27 with comorbidity) for weight-loss-indicated drugs, or T2D diagnosis with metformin trial for diabetes-indicated drugs. Step therapy requirements vary by plan.
White-glove telehealth focused on speed and ease. Strongest pick for patients paying cash who want a fast time-to-prescription path with minimal friction.
Direct-to-consumer compounded semaglutide subscription. Affordable but trades FDA-approval status for price predictability.
If insurance denies, the Alabama cash-pay route is LillyDirect vials ($349-499/mo depending on dose). Available nationally; ships to Alabama residents through manufacturer-direct fulfillment.
Editorial summary. Alabama licensure and insurance rules change quarterly; confirm with your prescriber and plan before relying on any single source. Affiliate disclosure: we earn commission on outbound clicks to provider partners.